CO-DIAGNOSTICS, INC. (CODX) Net income 2016–2025
CO-DIAGNOSTICS, INC. (CODX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$46.9MFY2025 · since FY2016: -$1.9M → -$46.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$46.9M | -24.6% |
| FY2024 | -$37.6M | -6.5% |
| FY2023 | -$35.3M | -148.2% |
| FY2022 | -$14.2M | -138.8% |
| FY2021 | $36.7M | -13.7% |
| FY2020 | $42.5M | +785.6% |
| FY2019 | -$6.2M | +1.2% |
| FY2018 | -$6.3M | +9.9% |
| FY2017 | -$7.0M | -260.8% |
| FY2016 | -$1.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CODX financial trends
CODX RevenueCODX Net marginCODX Gross profitCODX Gross marginCODX Operating incomeCODX Operating marginCODX Operating cash flowCODX Free cash flowCODX Capital expendituresCODX Return on equityCODX Stock buybacksCODX Dividends paidCODX Total assetsCODX Total liabilitiesCODX Shareholders’ equityCODX overview →